Appendix 2

Public hearings and witnesses

Monday, 30 March 2015—Canberra

HORNER, Ms Philippa, Principal Legal Advisor, Therapeutic Goods Administration, Department of Health

LEAHY, Mr Denis, National Councillor (New South Wales), Pharmacy Guild of Australia

LINKSON, Ms Marita, Executive Officer, Australian and New Zealand Society of Palliative Medicine

McDONALD, Mr David Neil, Secretary, Australian Capital Territory Branch, Public Health Association of Australia

MITCHELL, Dr Maureen, Member, Australian and New Zealand Society of Palliative Medicine

MOORE, Adjunct Professor Michael John, Chief Executive Office, Public Health Association of Australia

PENINGTON, Professor David, Emeritus Professor, University of Melbourne

SMYTH, Mr Nathan, First Assistant Secretary, Population Health Division, Department of Health

STUDDERT, Dr Lisa, Market Authorisation Group, Therapeutic Goods Administration, Department of Health

TODD, Mr Ian, National Councillor (South Australia), Pharmacy Guild of Australia

Tuesday, 31 March 2015—Sydney

ALLSOP, Dr David John, Private capacity

BATEY, Professor Robert Gordon, Fellow, Australasian Chapter of Addiction Medicine; Fellow, Royal Australasian College of Physicians

CALLAGHAN, Ms Liz, Chief Executive Officer, Palliative Care Australia

CHYE, Associate Professor Richard, Board Member, Palliative Care Australia

CROSSING, Ms Sally, Convener, Cancer Voices Australia

FEENEY, Mr Lance, Policy Analyst, National Association of People with HIV Australia, Australian Federation of AIDS Organisations, Positive Life New South Wales and ACON

HANSEN, Ms Linda, Executive Officer, Palliative Care New South Wales

HASLAM, Mrs Lucy Anne, Private capacity

HUNTIR, Mr Alex, Manager, Volunteer Support Services, Palliative Care New South Wales

IRELAND, Ms Carol, Chief Executive Officer, Epilepsy Action Australia

KRISHNASAMY, Professor Mei, President, Clinical Oncology Society of Australia

LINTZERIS, Associate Professor Nicholas, Private capacity

MATHER, Emeritus Professor Laurence Edward, Private Capacity

McGREGOR, Professor Iain Stewart, Private capacity

MELTON, Dr Lisa, Research Development Manager, MS Research Australia and MS Australia

MORRIS, Professor Philip LP, Fellow, Royal Australian and New Zealand College of Psychiatrists; Fellow, Australasian Chapter of Addiction Medicine; Fellow, Royal Australasian College of Physicians

MOSTYN, Mr Benjamin Thomas, Member, Australian Drug Law Reform Initiative

RITTER, Professor Alison, Director, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales

TODD, Ms Lisa, Clinical Governance Manager, Epilepsy Action Australia

WHITTAKER, Ms Kate, Manager, Cancer Care Policy, Cancer Council Australia

WODAK, Dr Alexander David, AM, Member, Executive Committee, Australian Drug Law Reform Initiative

Wednesday, 1 April 2015—Brisbane

BENHAIM, Mr Paul, Founder and Chief Executive Officer, Elixinol LLC

CARTER, Ms Lanai, Private capacity

COPE, Mr Michael James, President, Queensland Council for Civil Liberties

CRAWFORD, Ms Janice, Member, Criminal Law Committee, Bar Association of Queensland

GILLESPIE, Mr David, Chief Executive Officer, Agricultural Microbes Pty Ltd

HALL, Professor Wayne Denis, Private capacity

MILES, Mrs Rhonda, Private capacity

NEVILLE, Mr Paul Christopher, Private capacity

NEVILLE, Mrs Joelle Elizabeth, Private capacity

RANSLEY, Mr John Edward, Executive Member, Queensland Council for Civil Liberties

WACHTEL, Mr Boaz, Managing Director, Phytotech Medical Ltd

WILSON, Ms Elizabeth Sybil, QC, Chair, Criminal Law Committee, Bar Association of Queensland

Navigation: Previous Page | Contents | Next Page